UNIVERSITY OF NORTH CAROLINA HOSPITALS
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 1989-01-01
- Employees
- -
- Market Cap
- -
Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Conditions
- Interventions
- First Posted Date
- 2008-09-01
- Last Posted Date
- 2018-01-18
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 32
- Registration Number
- NCT00744354
- Locations
- ๐บ๐ธ
Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States
๐บ๐ธDuke Comprehensive Cancer Center, Durham, North Carolina, United States
๐บ๐ธMount Sinai Medical Center, New York, New York, United States
Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2007-12-14
- Last Posted Date
- 2012-04-24
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 31
- Registration Number
- NCT00573690
- Locations
- ๐บ๐ธ
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2007-08-23
- Last Posted Date
- 2012-03-06
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 47
- Registration Number
- NCT00520000
Individualized Exercise Programs for Patients Receiving Chemotherapy for Newly Diagnosed Acute or Relapsed Myeloid Leukemia or Lymphoblastic Leukemia
- Conditions
- First Posted Date
- 2007-07-11
- Last Posted Date
- 2012-03-06
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT00499759
- Locations
- ๐บ๐ธ
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2017-05-23
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 2
- Registration Number
- NCT00489216
- Locations
- ๐บ๐ธ
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer
- Conditions
- Interventions
- First Posted Date
- 2007-06-07
- Last Posted Date
- 2017-07-12
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 33
- Registration Number
- NCT00483405
- Locations
- ๐บ๐ธ
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
Visibility of Lesion Characteristics With Phase Contrast Mammography
- First Posted Date
- 2007-05-01
- Last Posted Date
- 2012-05-01
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 53
- Registration Number
- NCT00467727
- Locations
- ๐บ๐ธ
Carolina Center for Clinical Trials, University of North Carolina, Chapel Hill, North Carolina, United States
Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer
- First Posted Date
- 2007-03-30
- Last Posted Date
- 2017-07-11
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT00454324
- Locations
- ๐บ๐ธ
University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen
- Conditions
- Interventions
- First Posted Date
- 2007-03-16
- Last Posted Date
- 2017-07-17
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 54
- Registration Number
- NCT00448357
- Locations
- ๐บ๐ธ
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer
- First Posted Date
- 2006-09-22
- Last Posted Date
- 2017-03-21
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT00379509
- Locations
- ๐บ๐ธ
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States